Mass. Bio launches ad campaign, ups lobbying

The Massachusetts Biotechnology Council (MBC) has two big projects in the works: it's upping its lobbying spending and at the same time kicking off an ad campaign to boost its profile in the state. Recently, MBC has weathered controversy over the council's leadership--former MBC head Thomas Finneran pled guilty to obstruction of justice earlier this year--and its pay packages.

MBC's current CEO, Robert Coughlin, will be leading the effort in Washington to discuss issues such as patent reform and federal research funding. With the ad campaign, MBC hopes to raise local awareness of the work biotechs do in Massachusetts, and the contributions medical research will bring to public health in the future.

- read this article from the Boston Herald

Related Articles:
Mass. fills in the details on $1B biotech program. Report
Boston biotech booming as scientific research flourishes. Report
Massachusetts biotech council taps new president. Report
Mass. Bio's Finneran takes a felony plea deal. Report